This U.S. industry comprises establishments primarily engaged in manufacturing vaccines, toxoids, blood fractions, and culture media of plant or animal origin (except diagnostic). Establishments primarily engaged in--

Including:

• Agar culture media manufacturing
• Aggressins (except in-vitro) manufacturing
• Allergenic extracts (except diagnostic substances) manufacturing
• Allergens manufacturing
• Antigens manufacturing
• Antiserums manufacturing
• Antitoxins manufacturing
• Antivenoms manufacturing
• Bacterial vaccines manufacturing
• Bacterins (i.e., bacterial vaccines) manufacturing
• Blood derivatives manufacturing
• Blood fractions manufacturing
• Cholera serums manufacturing
• Culture media manufacturing
• Gene therapy preparations manufacturing
• Hematology products (except diagnostic substances) manufacturing
• Plasmas manufacturing
• Serums (except diagnostic substances) manufacturing
• Toxoids (e.g., diphtheria, tetanus) manufacturing
• Tuberculin (i.e., tuberculo-protein derived) manufacturing
• Vaccines (i.e., bacterial, virus) manufacturing
• Virus vaccines manufacturing